| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/15/2013 | CN102293889B Simotang dry suspension and preparation method thereof |
| 05/15/2013 | CN102284012B Gel plaster containing curcumin and bletilla hyacinthina gum and preparation method thereof |
| 05/15/2013 | CN102204908B Pharmaceutical composition containing edaravone compound, and preparation method thereof |
| 05/15/2013 | CN102058532B Compound dihydromyricetin oral aerosol and preparation method thereof |
| 05/15/2013 | CN101991589B Glycerol fructose injection and preparation method thereof |
| 05/15/2013 | CN101889996B Rectal administration composition containing tamsulosin |
| 05/15/2013 | CN101835464B Anti-malarial pharmaceutical composition |
| 05/15/2013 | CN101773511B Compound topical combination drug for treatment of acne and preparation method thereof |
| 05/15/2013 | CN101744841B Bifidobacterium for treating inflammatory disease |
| 05/15/2013 | CN101744285B Method for preparing emulsified and gelatinized functional fatty acid carrier |
| 05/15/2013 | CN101627056B Y-type polyethylene glycol modified g-csf and preparation method and use thereof |
| 05/15/2013 | CN101528780B Hyaluronic acid derivatives obtained via 'click chemistry' crosslinking |
| 05/15/2013 | CN101466407B Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
| 05/15/2013 | CN101171927B Choline-silicic acid complex with osmolytes and divalent trace elements |
| 05/14/2013 | US8440816 Branched polymers |
| 05/14/2013 | US8440814 Derivatives of cyclodextrins, process for their preparation and their use in particular for solubilizing pharmacologically active substances |
| 05/14/2013 | US8440726 Solubilizing composition |
| 05/14/2013 | US8440628 stable aqueous solution containing endogenous growth hormone secretagogues having pH range of 2 to 7; a pH adjuster or a buffer agent; nondegradation, storage stability; biodrug inducing the secretion of growth hormone |
| 05/14/2013 | US8440623 Polymer stabilized neuropeptides |
| 05/14/2013 | US8440309 Crosslinked polymers with the crosslinker as therapeutic for sustained release |
| 05/14/2013 | US8440229 Hollow silica nanospheres and methods of making same |
| 05/14/2013 | US8440220 Sustained release of drug antagonist; analgesic reservoir, barrier layer |
| 05/14/2013 | US8440219 Reduced-odor thiol compositions |
| 05/14/2013 | US8440175 Hair cosmetic composition |
| 05/14/2013 | CA2734403C Nicotine-containing product |
| 05/14/2013 | CA2682587C Water-soluble iron(iii)-carbohydrate derivative complexes, preparation thereof, and medicaments comprising them |
| 05/14/2013 | CA2602210C Tablet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo |
| 05/14/2013 | CA2567075C Pharmaceutical suspension composition |
| 05/14/2013 | CA2548202C Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 05/14/2013 | CA2544814C Non-symmetrical gelling agent |
| 05/14/2013 | CA2539982C Pantoprazole multiparticulate formulations |
| 05/14/2013 | CA2516624C 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders |
| 05/14/2013 | CA2516399C Pharmaceutical compositions of safingol and methods of using the same |
| 05/14/2013 | CA2491136C A chemical carrier |
| 05/14/2013 | CA2477878C Peptides selectively lethal to malignant and transformed mammalian cells |
| 05/14/2013 | CA2465753C Orodispersible tablet having high homogeneity and the preparation method thereof |
| 05/14/2013 | CA2460352C Composition and transdermal drug delivery device |
| 05/14/2013 | CA2389487C Process for the production of a reversibly inactive acidified plasmin composition |
| 05/14/2013 | CA2362606C Therapeutic antimicrobial compositions |
| 05/10/2013 | WO2013067537A1 Nanoparticle-based drug delivery |
| 05/10/2013 | WO2013067483A1 Delivery systems for improving oral bioavailability of fenobam, its hydrates, and salts |
| 05/10/2013 | WO2013067449A1 Pharmaceutical compositions of hydrophobic camptothecin derivatives |
| 05/10/2013 | WO2013067346A1 Dermal delivery compositions and methods |
| 05/10/2013 | WO2013067022A1 Formulations for the treatment of diabetes |
| 05/10/2013 | WO2013066903A1 Combinational liposome compositions for cancer therapy |
| 05/10/2013 | WO2013065720A1 Ophthalmological aqueous composition |
| 05/10/2013 | WO2013065719A1 Ophthalmological aqueous composition |
| 05/10/2013 | WO2013065068A1 Oral disintegrating composition of anti-histamine agents |
| 05/10/2013 | WO2013065051A1 Formulation and device for treating ceruminosis |
| 05/10/2013 | WO2013065009A1 A sortase-click reaction suite for synthesis of multivalent dendrimeric protein assembly |
| 05/10/2013 | WO2013064787A1 Quick-acting insulin formulation including an oligosaccharide |
| 05/10/2013 | WO2013064669A1 Glp-1 receptor agonist peptide gastrin conjugates |
| 05/10/2013 | WO2013064508A1 Polyethylene glycol based prodrug of adrenomedullin and use thereof |
| 05/10/2013 | WO2013064455A1 Tyrosine based linkers for the releasable connection of peptides |
| 05/10/2013 | WO2013064153A1 Prodrugs of non- steroid anti - inflammatory agents (nsaids) |
| 05/10/2013 | WO2013063695A1 Compositions and methods for preventing and treating oral diseases |
| 05/10/2013 | WO2013038271A4 Fill formulations and capsules and method of use to avoid migration of fill into or through the shell |
| 05/10/2013 | WO2013037965A3 Ionic gel |
| 05/10/2013 | WO2013036309A3 Sustained release formulations for delivery of proteins to the eye and methods of preparing same |
| 05/10/2013 | WO2013032828A3 Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking |
| 05/10/2013 | WO2013032210A3 Biomembrane permeable composition |
| 05/10/2013 | WO2013032201A3 Material for preventing adhesion, and method for preventing adhesion |
| 05/10/2013 | WO2013030535A3 Method of preparing carrier liquids |
| 05/10/2013 | WO2013022783A3 Progesterone containing oral dosage forms and related methods |
| 05/10/2013 | WO2013012628A3 Immune-stimulating photoactive hybrid nanoparticles |
| 05/10/2013 | WO2012177653A3 Targeting the neuromuscular junction for treatment |
| 05/10/2013 | WO2012140650A3 Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof |
| 05/10/2013 | WO2012128628A9 Immunogenic compositions in particulate form and methods for producing the same |
| 05/10/2013 | WO2011119487A3 Compositions and methods useful for stabilizing protein-containing formulations |
| 05/10/2013 | CA2854612A1 Delivery systems for improving oral bioavailability of fenobam, its hydrates, and salts |
| 05/10/2013 | CA2854361A1 Subcutaneous delivery of polymer conjugates of therapeutic agents |
| 05/10/2013 | CA2854164A1 Dermal delivery compositions and methods |
| 05/10/2013 | CA2854134A1 Polyethylene glycol based prodrug of adrenomedullin and use thereof |
| 05/10/2013 | CA2854095A1 Tyrosine based linkers for the releasable connection of peptides |
| 05/10/2013 | CA2853942A1 Formulations for the treatment of diabetes |
| 05/10/2013 | CA2853884A1 Glp-1 receptor agonist peptide gastrin conjugates |
| 05/10/2013 | CA2853857A1 Compositions and methods for preventing and treating oral diseases |
| 05/10/2013 | CA2853235A1 Ophthalmological aqueous composition |
| 05/10/2013 | CA2853233A1 Ophthalmological aqueous composition |
| 05/10/2013 | CA2852564A1 Combinational liposome compositions for cancer therapy |
| 05/10/2013 | CA2850955A1 Pharmaceutical compositions of hydrophobic camptothecin derivatives |
| 05/10/2013 | CA2794445A1 Organogel compositions comprising alkylated benzimidazolones |
| 05/09/2013 | US20130116427 Cellulose interpolymers and method of oxidation |
| 05/09/2013 | US20130116426 Cellulose interpolymers and method of oxidation |
| 05/09/2013 | US20130116425 Cellulose interpolymers and method of oxidation |
| 05/09/2013 | US20130116407 Controlled release from macromolecular conjugates |
| 05/09/2013 | US20130116341 In-vivo gelling pharmaceutical pre-formulation |
| 05/09/2013 | US20130116338 Nanometal dispersion and method for preparing the same |
| 05/09/2013 | US20130116328 Thermogelling Anaesthetic Compositions |
| 05/09/2013 | US20130116316 Solid Pharmaceutical Compositions Containing Benzofuran Derivatives |
| 05/09/2013 | US20130116306 System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron |
| 05/09/2013 | US20130116261 Nanoparticles for encapsulation of compounds, the production and uses thereof |
| 05/09/2013 | US20130116255 Combination of brimonidine and timolol for topical ophthalmic use |
| 05/09/2013 | US20130116212 Oil-based gel-like composition |
| 05/09/2013 | US20130116191 Transport protein which is used to introduce chemical compounds into nerve cells |
| 05/09/2013 | US20130116178 Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons |
| 05/09/2013 | US20130115306 Toxin decontaminant food product and method of treating disorders of the gastrointestinal tract |
| 05/09/2013 | US20130115285 Enteric coating compositions and methods of making and using the same |
| 05/09/2013 | US20130115268 Methods of Administering a Dermatological Agent to a Subject |
| 05/09/2013 | US20130115253 Sustained Release Suspension Preparation For Dextromethorphan |